BioSpace News Archive

Anavex Life Sciences Corp. announced that the first patients with Rett syndrome from the ANAVEX®2-73-RS-003 study are able to continue treatment with ANAVEX®2-73 thanks to Health Canada’s approval of the Special Access Program, allowing for compassionate use following completion of the 48-week Open-Label Extension study.

Hemab Therapeutics announced it will present data from preclinical research of HMB-001 in Factor VII deficiency at the upcoming International Society on Thrombosis and Haemostasis 2023 Congress, June 24 – 28, in Montreal.

Biostar Pharma, Inc. is pleased to announce that, after having in-depth discussions with the FDA through pre-IND meetings, the FDA has approved the IND of a phase 2/3 clinical trial with seamless protocol design for the company’s core product utidelone injectable in patients with locally advanced or metastatic non-small cell lung cancer.

Cantex Pharmaceuticals, Inc. announced that it will present at the MedInvest Oncology Investor Conference being held June 21-22, 2023, in Boston, MA.

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the appointment of Greg Perry as the Company’s Chief Financial Officer.

Impel Pharmaceuticals announced it will present new real-world data adding to the growing body of evidence supporting Trudhesa® nasal spray as an effective acute therapy for migraine management.

TRACON Pharmaceuticals, Inc. announced that it has commenced court proceedings in Hong Kong and the Cayman Islands to enforce an April 2023 arbitration award against I-Mab for approximately $23.0 million, plus interest.

Sensus Healthcare, Inc. announces its participation in the Maxim Group Virtual Healthcare Conference hosted by M-Vest.

Satsuma Pharmaceuticals, Inc., and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd., announced that three abstracts describing efficacy and safety results from the STS101 Phase 3 efficacy trial were selected for presentation at the American Headache Society’s 65th Annual Scientific Meeting.

Daxor Corporation announces the launch of a new service designed to drive faster adoption and provide greater prescriber access to Daxor’s innovative blood volume analysis technology.